A PARK2 polymorphism associated with delayed neuropsychological sequelae after carbon monoxide poisoning

BMC Medical Genetics

Volumn 14, Issue 1, 2013, Pages

  Liang, Fei ^a,b   Li, Wenqiang ^a   Zhang, Ping ^a   Zhang, Yanxia ^a   Gu, Jiapeng ^a   Wang, Xiahong ^c   Zhang, Hongxing ^a   Gu, Renjun ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b Xinxiang Medical University ^*  (China)

^c XINXIANG CENTRAL HOSPITAL   (China)

Author keywords

Acute carbon monoxide poisoning; Delayed neuropsychological sequelae; PARK2; SNP

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTICLE; CARBON MONOXIDE INTOXICATION; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARK2 GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; CARBON MONOXIDE POISONING; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; UBIQUITIN-PROTEIN LIGASES;

EID: 84884527350     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-14-99     Document Type: Article

References (29)

1. Ernst A, Zibrak JD. Carbon monoxide poisoning. N Engl J Med 1998, 339(22):1603-1608. 10.1056/NEJM199811263392206, 9828249.
2. Choi IS. Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol 1983, 40(7):433-435. 10.1001/archneur.1983.04050070063016, 6860181.
3. Ginsberg MD. Delayed neurological deterioration following hypoxia. Arch Neurol 1979, 26:21-44.
4. Shprecher D, Mehta L. The syndrome of delayed post-hypoxic leukoencephalopathy. NeuroRehabilitation 2010, 26(1):65-72. 2835522, 20166270.
5. Teksam M, Casey SO, Michel E, Liu H, Truwit CL. Diffusion-weighted MR imaging findings in carbon monoxide poisoning. Neuroradiology 2002, 44(2):109-113. 10.1007/s002340100639, 11942360.
6. Watanabe N, Nohara S, Matsuda H, Sumiya H, Noguchi K, Shimizu M, Tsuji S, Kinuya S, Shuke N, Yokoyama K, et al. Statistical parametric mapping in brain single photon computed emission tomography after carbon monoxide intoxication. Nucl Med Commun 2002, 23(4):355-366. 10.1097/00006231-200204000-00009, 11930189.
7. Pepe G, Castelli M, Nazerian P, Vanni S, Del Panta M, Gambassi F, Botti P, Missanelli A, Grifoni S. Delayed neuropsychological sequelae after carbon monoxide poisoning: predictive risk factors in the Emergency Department, a retrospective study. Scand J Trauma Resusc Emerg Med 2011, 19:16. 10.1186/1757-7241-19-16, 3065430, 21414211.
8. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008, 79(4):368-376. 10.1136/jnnp.2007.131045, 18344392.
9. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392(6676):605-608. 10.1038/33416, 9560156.
10. Gaweda-Walerych K, Safranow K, Jasinska-Myga B, Bialecka M, Klodowska-Duda G, Rudzinska M, Czyzewski K, Cobb SA, Slawek J, Styczynska M, et al. PARK2 variability in Polish Parkinson's disease patients - interaction with mitochondrial haplogroups. Parkinsonism Relat Disord 2012, 18(5):520-524. 10.1016/j.parkreldis.2012.01.021, 3358581, 22361577.
11. Li J, Liu H, Liu J, Fu X, Yu Y, Yu G, Chen S, Chu T, Lu N, Bao F, et al. Association study of the single nucleotide polymorphisms of PARK2 and PACRG with leprosy susceptibility in Chinese population. Eur J Med Genet 2012, 20(5):488-489.
12. Yang KC, Ku HL, Wu CL, Wang SJ, Yang CC, Deng JF, Lee MB, Chou YH. Striatal dopamine transporter binding for predicting the development of delayed neuropsychological sequelae in suicide attempters by carbon monoxide poisoning: a SPECT study. Psychiatry Res 2011, 194(3):219-223. 10.1016/j.pscychresns.2011.04.006, 22044533.
13. Li WQ, Gu RJ, Zhang YX, Zhang P, Liang F, Gu JP. DNA pooling base genome-wide association study identifies variants at NRXN3 associated with delayed encephalopathy after acute carbon monoxide poisoning. PloS one 2013, in press.
14. Miller DH, Leary SM. Primary-progressive multiple sclerosis. Lancet Neurol 2007, 6(10):903-912. 10.1016/S1474-4422(07)70243-0, 17884680.
15. Kamali-Sarvestani E, Nikseresht AR, Aliparasti MR, Vessal M. IL-8 (-251 A/T) and CXCR2 (+1208 C/T) gene polymorphisms and risk of multiple sclerosis in Iranian patients. Neurosci Lett 2006, 404(1-2):159-162.
16. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, Wang HH, Yao A, Chen YT, Hsu CN. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006, 34:W635-41. 10.1093/nar/gkl236, 1538865, 16845089.
17. Solé X, Guinó E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22(15):1928-1929. 10.1093/bioinformatics/btl268, 16720584.
18. Poulogiannis G, McIntyre RE, Dimitriadi M, Apps JR, Wilson CH, Ichimura K, Luo F, Cantley LC, Wyllie AH, Adams DJ, et al. PARK2 Deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc Natl Acad Sci U S A 2010, 107(34):15145-15150. 10.1073/pnas.1009941107, 2930574, 20696900.
19. Ali S, Vollaard AM, Widjaja S, Surjadi C, Van de Vosse E, Van Dissel JT. PARK2/PACRG polymorphisms and susceptibility to typhoid and paratyphoid fever. Clin Exp Immunol 2006, 144(3):425-431. 10.1111/j.1365-2249.2006.03087.x, 1941982, 16734611.
20. Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, et al. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet 2010, 42(1):77-82. 10.1038/ng.491, 19946270.
21. Pankratz N, Dumitriu A, Hetrick KN, Sun M, Latourelle JC, Wilk JB, Halter C, Doheny KF, Gusella JF, Nichols WC, et al. Copy number variation in familial Parkinson disease. PloS one 2011, 6:e20988. 10.1371/journal.pone.0020988, 3149037, 21829596.
22. Cummings AC, Lee SL, McCauley JL, Jiang L, Crunk A, McFarland LL, Gallins PJ, Fuzzell D, Knebusch C, Jackson CE, et al. A genome-wide linkage screen in the Amish with Parkinson disease points to chromosome 6. Ann Hum Genet 2011, 75(3):351-358. 10.1111/j.1469-1809.2011.00643.x, 3077806, 21488853.
23. Kay DM, Stevens CF, Hamza TH, Montimurro JS, Zabetian CP, Factor SA, Samii A, Griffith A, Roberts JW, Molho ES, et al. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2. Neurology 2010, 75(13):1189-1194. 10.1212/WNL.0b013e3181f4d832, 3013490, 20876472.
24. Sriram K, Lin GX, Jefferson AM, Roberts JR, Wirth O, Hayashi Y, Krajnak KM, Soukup JM, Ghio AJ, Reynolds SH, et al. Mitochondrial dysfunction and loss of Parkinson's disease-linked proteins contribute to neurotoxicity of manganese-containing welding fumes. FASEB J 2010, 24(12):4989-5002. 10.1096/fj.10-163964, 20798247.
25. Scheuerle A, Wilson K. PARK2 copy number aberrations in two children presenting with autism spectrum disorder: further support of an association and possible evidence for a new microdeletion/microduplication syndrome. Am J Med Genet B Neuropsychiatr Genet 2011, 156B(4):413-420.
26. Ros R, Ampuero I, Garcia de Yebenes J. Parkin polymorphisms in progressive supranuclear palsy. J Neurol Sci 2008, 268(1-2):176-178.
27. Liang CS, Chou MK, Yang FW. Delayed-onset diurnal bruxism, psychic akinesia and depression after carbon monoxide poisoning: a case report. Gen Hosp Psychiatry 2011, 33(1):82 e9-10.
28. Hu H, Pan X, Wan Y, Zhang Q, Liang W. Factors affecting the prognosis of patients with delayed encephalopathy after acute carbon monoxide poisoning. Am J Emerg Med 2011, 29(3):261-264. 10.1016/j.ajem.2009.09.030, 20825794.
29. Lo CP, Chen SY, Chou MC, Wang CY, Lee KW, Hsueh CJ, Chen CY, Huang KL, Huang GS. Diffusion-tensor MR imaging for evaluation of the efficacy of hyperbaric oxygen therapy in patients with delayed neuropsychiatric syndrome caused by carbon monoxide inhalation. Eur J Neurol 2007, 14:777-782. 10.1111/j.1468-1331.2007.01854.x, 17594334.